Review of Preclinical and Clinical Studies of Bone Marrow-Derived Cell Therapies for Intracerebral Hemorrhage

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/sci/volume-2016/4617983/figures/4617983.fig.003a.svgz" name="4617983.fig.003a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Time of latest behavioral test</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/sci/volume-2016/4617983/figures/4617983.fig.003b.svgz" name="4617983.fig.003b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Minimal number of animals per group (behavioral test)</td></tr></table>

<div>Charts summarizing the timing of the latest behavioral test (a) and the minimal number of animals per experimental group (b) in preclinical studies that have evaluated the therapeutic potential of bone marrow-derived cells for hemorrhagic stroke.</div>

Stem Cells International

fig3

Figure 3

Figure 3: Review of Preclinical and Clinical Studies of Bone Marrow-Derived Cell Therapies for Intracerebral Hemorrhage 